Global Closed System Drug Transfer Devices Market Size Likely to Grow at a CAGR of 8.3% By 2035

Market Size and Growth

The market size of closed system drug transfer devices is estimated at USD 1.47 billion in 2025 and will grow at a CAGR of 8.3% between the years 2026 and 2035 with an estimated market size of USD 1.58 billion in 2026 and USD 3.21 billion in 2035.

Closed System Drug Transfer Devices Market Revenue and Trends

A global marketplace in closed system drug transfer devices (CSTDs) offers engineered safety systems to preclude the release of dangerous drug vapours, aerosols and particulates in the course of the preparation, transfer, and administration of cytotoxic, antineoplastic, and other risky drugs in oncology, pharmacy compounding and hospital environments.

The world CSTD market has been expanding at an alarming rate, owing to heightened application of hazardous drugs, more rigorous occupational safety standards, exponential growth in cancer rates, a rising oncology drug pipeline, and more next generation mechanically- and membrane-based closed systems in healthcare and pharmacy systems across the world.

What are the Factors That Have a Significant Contribution to the Growth of the closed system drug transfer devices market?

Due to the increased use of biologics, monoclonal antibodies, and high-potency active pharmaceutical ingredients (HPAPIs), as well as the increasing number of patients with cancer, CSTD products have gained more, which has increased the demand for CSTD products. Due to the rising chemotherapy volumes and compounding demands across the world, more facilities will want compliant and leak-proof systems to reduce exposures and adhere to safety standards.

There are other technological innovations, such as dry connections where there are two membranes, push-to-turn, low-residue, and built-in venting filters that have enhanced usability, decreased priming volume, and better containment performance. Further causes are also the USP compliance enforcement that has been reinforced, the expanded reimbursement of safe handling practices, and the government regulatory programs that promote occupational health and safety of hazardous drugs in developed and new areas.

Segment Insight

By Product Type

Membrane-to-membrane CSTDs have since been by far the largest percentage of the closed system drug transfer devices market as of 2025 with strong demand in hospital pharmacy and oncology compounding leading to continued development of low-spill, high-flow, and universal compatibility designs, which pharmacists and nurses across the board have cited as superior devices to increase their safety and workflow efficiency.

By Distribution Channel

The biggest market share is in the direct sales to hospitals, oncology centers and compounding pharmacies, which are the main centers of acquiring high quality CSTD systems, staff training, and support in hazardous drug handling policies. These channels have since been a source of choice with regard to the sourcing of closed system drug transfer devices since they offer professional expertise in system validation, compatibility testing, and regulatory compliance guidance.

Regional Insights

North America has conquered the marketplace of closed system drug transfer devices globally due to strict occupational safety standards (USP <800> NIOSH guidelines), high usage of oncology drugs, and increased usage of highly sophisticated containment devices. North America is also enjoying strong reimbursement support and the availability of extensive specialty compounding facilities, as well as the early adoption of next-generation membrane and dry-connection systems. The availability of the large industry players and continuous clinic safety studies and government regulation favor the further hegemonic position of the North American region.

Moreover, it is showing the most growth in Asia Pacific in the closed system drug transfer devices market due to its fast-growing oncology care system, rising cancer rates, growing use of suspicious drug compounds, and tightening regulation systems. The adoption of CSTD has been on an apparent upward trend in China, India, Japan, and South Korea because affordability has been increasing, there is an increase in awareness of healthcare worker safety, and cancer control and hospital safety programs are growing and supported by the government. This will increase the rate at which the oncology centers, chemotherapy volumes, and regulatory harmonization accelerate in the region, leading to quick growth in the market in the Asia pacific.

Report Scope

Recent Developments

• In November 2025: B. Braun launched the OnGuard® 2 CSTD system with enhanced dry spike and dry connect technology, delivering improved flow rates, reduced priming volume, and superior vapor containment for high-throughput oncology pharmacy compounding and administration.

List of the prominent players in the Closed System Drug Transfer Devices Market:

• BD (Becton Dickinson and Company)

• ICU Medical Inc.

• B. Braun Melsungen AG

• Corvida Medical

• Equashield

• Simplivia Healthcare Ltd.

• JMS Co. Ltd.

• Baxter International Inc.

• Victus Inc.

• Yukon Medical

• Carefusion (Cardinal Health)

• Hospira (Pfizer)

• Others

The Closed System Drug Transfer Devices Market is segmented as follows:

By Component

• Vial Access Devices

• Syringe Safety Devices

• Bag/Line Access Devices

• IV Line Access Components

• Needleless Connectors

• Other Components

By Technology

• Membrane-to-Membrane Systems

• Needle-Based Systems

• Luer Lock Systems

• Other Technologies

• By Application

• Oncology/Chemotherapy

• Hazardous Drug Handling

o   Antineoplastic Drugs

o   Biologic Agents

o   Antiviral Medications

o   Other Hazardous Drugs

• Non-Hazardous Drug Preparation

• Compounding Applications

• Other Applications

By End User

• Hospitals and Healthcare Facilities

o   Hospital Pharmacies

o   Oncology Departments

o   Infusion Centers

• Oncology Centers

• Pharmaceutical Manufacturing

• Compounding Pharmacies

• Other End Users

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America